EIB provides €15 million to fund coronavirus research at IRBM

Rome, Italy, 21st April – IRBM SpA (‘IRBM’) today announced that the European Investment Bank (EIB) provides €15 million in funding to IRBM SpA, a globally oriented Italian company specialising in research and development for new biomedical and pharmaceutical solutions to combat rare, infectious, oncologic and neurological diseases. The EIB financing is supported by the Infectious Diseases Finance Facility window under the EU’s InnovFin – EU finance for innovators programme, backed by the European Union’s research and innovation programme Horizon 2020.

Read the full release here.